Klastrup, V., Gunst, J. D.
, Rasmussen, T. A., Tolstrup, M. & Søgaard, O. S. (2025).
Factors influencing virologic control during analytical treatment interruptions in HIV cure trials - a pooled analysis of individual level data.
The Journal of Infectious Diseases,
232(1), 69-78.
https://doi.org/10.1093/infdis/jiaf163
Gullaksen, S., Funck, K. L., Bek, T., Sørensen, S. S., Poulsen, P. L., Vernstrøm, L., Petersen, L. & Laugesen, E. (2024).
Semaglutide does not affect central retinal thickness beyond the effect explained by glycaemic change: continuous glucose monitoring in persons with type 2 diabetes.
Diabetologia,
Suppl. 1(1-593 (2024)).
https://doi.org/10.1007/s00125-024-06226-0
Gullaksen, S., Vernstrøm, L., Sørensen, S. S., Funck, K. L., Petersen, L., Bek, T., Laugesen, E. & Poulsen, P. L. (2023).
Effects of 32 weeks' treatment with semaglutide, empagliflozin or the combination on retinal oxygenation, vessel diameter and central retinal thickness.
Diabetologia,
66 (Sup1)(1–536 (2023)).
https://doi.org/10.1007/s00125-023-05969-6
Duus, L., Schachsen, P. K.
, Gertsen, J. B., Astvad, K. M. T.
& Kristensen, L. (2025).
Terbinafine Resistance in Trichophyton Species From Patients With Recalcitrant Infections Detected by the EUCAST Broth Microdilution Method and DermaGenius Resistance Multiplex PCR Kit.
Mycoses,
68(1), Article e70011.
https://doi.org/10.1111/myc.70011Willmann, J., Balermpas, P., Rimner, A., Appelt, A. L., Vasquez Osorio, E. M.
, Rønde, H. S., Day, M., Embring, A., Gabryś, D., Guren, M. G., Hoskin, P., Massaccesi, M., Mayo, C., Murray, L., Nieder, C., Guckenberger, M. & Andratschke, N. (2025).
Ongoing prospective studies on reirradiation: A systematic review of a clinical trials database.
Radiotherapy and Oncology,
202, Article 110624.
https://doi.org/10.1016/j.radonc.2024.110624Sørensen, J. K., Grevstad, U.
, Qerama, E., Bruun, L. S.
, Nikolajsen, L. & Runge, C. (2025).
Effect of local anesthetic volume for popliteal plexus block on motor nerve conduction and muscle function in the leg: a randomized clinical trial in healthy volunteers.
Regional Anesthesia and Pain Medicine, Article rapm-2025-106557. Advance online publication.
https://doi.org/10.1136/rapm-2025-106557
Depani, S., Vasiljevic, A., Mynarek, M., Dufour, C., Pfaff, E., Maaz, A. U., Guerrini-Rousseau, L., Doz, F., Hasselblatt, M., Ajithkumar, T., Aquilina, K., Schuhmann, M. U., Hoving, E., Tietze, A., Löbel, U., Pizer, B.
& Hoff, K. V. (2025).
European clinical practice recommendations for the diagnosis and treatment of paediatric pineal tumours.
EJC Paediatric Oncology,
5, Article 100217.
https://doi.org/10.1016/j.ejcped.2025.100217Thomsen, M., Busk, M., Zhang, D., Chiu, C.-L., Zhao, H., Garcia-Marques, F. J., Bermudez, A., Pitteri, S.
, Borre, M., Brooks, J. D.
& Nyengaard, J. R. (2025).
The olfactory receptor OR51E2 regulates prostate cancer aggressiveness and modulates STAT3 in prostate cancer cells and in xenograft tumors.
BMC Cancer,
25(1), Article 535.
https://doi.org/10.1186/s12885-025-13928-0
Chiu, C.-L., Zhang, D., Zhao, H., Wei, Y., Polasko, A. L.
, Thomsen, M., Yang, V., Yang, K. K., Hauck, S., Peterson, E., Wen, R., Qiu, Z., Corey, E., Miao, Y. R., Rankin, E., Peehl, D., Huang, J., Giaccia, A. & Brooks, J. (2025).
Targeting AXL Inhibits the Growth and Metastasis of Prostate Cancer in Bone.
Clinical Cancer Research,
31(7), 1346-1358.
https://doi.org/10.1158/1078-0432.CCR-24-3028Balle, C. M., Lildballe, D. L., Bedei, I., Luschka, R.
, Skakkebæk, A., Chang, S., Agirman, Z., Keller, J., Weber, A., Schäfer, R. E., Becker-Follmann, J.
& Gravholt, C. H. (2025).
Reliable detection of sex chromosome abnormalities by quantitative fluorescence polymerase chain reaction.
Clinical Chemistry and Laboratory Medicine,
63(8), 1519-1527.
https://doi.org/10.1515/cclm-2024-1400